|
|
CMS establishes new code and separate therapeutic class "Injection, Immune Globulin, Subcutaneous"
-
Medicare B Durable Medical Equipment Regional Carriers Approves Subcutaneous Immune Globulin to External Infusion Pumps LCD
-
Vivaglobin®, pump, tubing & ancillaries are reimbursed by the DMERC
-
Durable Medical Equipment Regional Carriers
-
CMS establishes new code and separate therapeutic class “Injection, Immune Globulin, Subcutaneous”
A HCPCS application for a separate J Code for Vivaglobin®, Immune Globulin Subcutaneous has been submitted to the Centers for Medicare and Medicaid.
The preliminary decision from CMS concerning this application states the establishment of a new code and separate therapeutic class, “Injection, Immune Globulin, Subcutaneous. In a Public Hearing on May 11, 2006 we requested a change in unit dosing from .5 grams to 1 ml as Vivaglobin® a 16% solution does not fit the .5 gram unit of measure. ZLB Behring anticipates the assignment of this code sometime in October 2006. The unique J-Code for immune globulin subcutaneous would be in effect beginning January 1, 2007. To date Vivaglobin® will be the only FDA approved drug in this therapeutic class.
CMS Preliminary Coding Decision 
Please contact the ZLB Reimbursement Answerline at 1-800-676-4266 for any questions concerning any ZLB product.
Display a print-friendly version of this issue:
Reimbursement Alert Online August 2006
Previous:
Durable Medical Equipment Regional Carriers
ZLB Behring assumes no responsibility for the individual interpretation of any material, facts, or references provided within the context of its publication of Reimbursement alert.
|